Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00016029
DRKS00016029
Completed
Not Applicable

Evaluation of serum-biomarkers as a surrogate marker for florid MS lesions (contrast enhancement) in patients with multiple sclerosis. - REDUCE-GAD

Klinikum der Johann Wolfgang Goethe-Universität Zentrum der Neurologie und Neurochirurgie0 sites102 target enrollmentJanuary 25, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsG35Multiple sclerosis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
G35
Sponsor
Klinikum der Johann Wolfgang Goethe-Universität Zentrum der Neurologie und Neurochirurgie
Enrollment
102
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 25, 2019
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinikum der Johann Wolfgang Goethe-Universität Zentrum der Neurologie und Neurochirurgie

Eligibility Criteria

Inclusion Criteria

  • •Planned implementation of a contrast enhanced cerebral or spinal MRI in patients with multiple sclerosis (including clinically isolated syndrome and radiologically isolated syndrome)

Exclusion Criteria

  • •Age of patient \< 18 years, other current present neurological diseases such as stroke, dementia, M. Parkinson or similar.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Markers in abdominal trauma
CTRI/2021/04/032510Department of general surgery IMS BH
Recruiting
Not Applicable
Clinical study for evaluating serum/plasma biomarker levels of healthy subjects to compare with these of patients with lung diseases.Healthy subjects
JPRN-UMIN000020502Department of Respiratory Medicine, Kyorin University School of Medicine100
Recruiting
Not Applicable
Clinical study on serum biomarkers associated with prognosis and pathology of POEMS syndromePOEMS syndrome
JPRN-UMIN000044082Department of Neurology, Graduate School of Medicine, Chiba University100
Not yet recruiting
Not Applicable
ongitudinal study of biological surrogate markers in primary progressive Multiple Sclersosis.MS10012303
NL-OMON31170Vrije Universiteit Medisch Centrum20
Completed
Phase 3
Exploratory analysis of serum and urine biomarkers associated with nausea and vomittings induced by highly emetogenic chemotherapy (Biomarker study of TRIPLE)Thoracic tumor
JPRN-UMIN000006143Division of thoracic oncology, Shizuoka Cancer Center80